Concepedia

Author

Peter Heering

Heinrich Heine University Düsseldorf

Also Known As

Heering, Peter, Michael Ott, P Heering, P J Heering, P. HEERING, P. Heering, P. J. Heering, P.J Heering, P.J. Heering, PETER J. HEERING

149

Publications

3.1K

Citations

31

H-Index

82

Concepts

All Affiliations

Heinrich Heine University DüsseldorfStädtisches Klinikum SolingenUniversity of CologneDüsseldorf University Hospital
PH

About

Peter Heering is an author at Heinrich Heine University Düsseldorf specializing in medicine, nephrology, and chronic kidney disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

18

25

1.3K

2

Allergy

2

2

56

3

Cellular Physiology

2

2

97

4

Public Health

1

1

75

5

Biochemistry

1

1

27

Peter Heering

×

51

Publications

2.7K

Citations

31

H-Index

YearCitations

Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration

Peter Heering, Stanislao Morgera, Florian Schmitz,

Intensive Care Medicine

1997

258

A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis

Howard Trachtman, Fernando C. Fervenza, Debbie S. Gipson,

Kidney International

2011

251

Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial

Gerd R. Hetzel, Martina Schmitz, H. Wissing,

Nephrology Dialysis Transplantation

2010

246

Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : Workshop recommendations

D C Cattran, Efstathios Alexopoulos, Peter Heering,

Kidney International

2007

190

Restenosis after elective coronary balloon angioplasty in patients with end stage renal disease: a case-control study using quantitative coronary angiography

F. C. Schoebel, F. Gradaus, Katrin Ivens,

Heart

1997

109

Systemic mycophenolate mofetil in comparison with systemic cyclosporin A in high-risk keratoplasty patients: 3 years' results of a randomized prospective clinical trial

Thomas Reinhard, Alexander Reis, Daniel Böhringer,

Graefe s Archive for Clinical and Experimental Ophthalmology

2001

78

Cardiovascular risk factors and diseases after renal transplantation

Sendogan Aker, Katrin Ivens, B. Grabensee,

International Urology and Nephrology

1998

75

Cardiovascular complications after renal transplantation

Sendogan Aker, Katrin Ivens, Zhen Guo,

Transplantation Proceedings

1998

74

Cyclosporine A and FK506 Inhibit Transcriptional Activity of the Human Mineralocorticoid Receptor: A Cell-Based Model to Investigate Partial Aldosterone Resistance in Kidney Transplantation

Christine E. Deppe, Peter Heering, Say Viengchareun,

Endocrinology

2002

70

Renal IL-17 expression in human ANCA-associated glomerulonephritis

Joachim Velden, Hans‐Joachim Paust, Elion Hoxha,

American Journal of Physiology-Renal Physiology

2012

68

Page 1